Europe Tissue Diagnostics Market Size & Outlook, 2024-2030
Related Markets
Europe tissue diagnostics market highlights
- The Europe tissue diagnostics market generated a revenue of USD 2,442.1 million in 2024.
- The market is expected to grow at a CAGR of 8.8% from 2025 to 2030.
- In terms of segment, immunohistochemistry was the largest revenue generating technology in 2024.
- Digital Pathology and Workflow is the most lucrative technology segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2025 to 2030.
Europe data book summary
| Market revenue in 2024 | USD 2,442.1 million |
| Market revenue in 2030 | USD 4,011.8 million |
| Growth rate | 8.8% (CAGR from 2025 to 2030) |
| Largest segment | Immunohistochemistry |
| Fastest growing segment | Digital Pathology and Workflow |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Immunohistochemistry, In situ Hybridization, Primary & Special Staining, Digital Pathology and Workflow, Anatomic Pathology, Molecular Pathology |
| Key market players worldwide | Roche Holding AG ADR, Abbott Laboratories, Thermo Fisher Scientific Inc, Siemens AG, Danaher Corp, BioMerieux SA, Qiagen NV, BD, Merck KGaA, GE Aerospace, Agilent Technologies Inc, Biogenex, Cell Signaling Technology, Bio SB, DiaGenic |
Other key industry trends
- In terms of revenue, Europe region accounted for 28.0% of the global tissue diagnostics market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 2,805.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Tissue Diagnostics Market Scope
Tissue Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| DiaGenic | View profile | 11-50 | Oslo, Oslo, Norway, Europe | http://www.diagenic.com/ |
| Cell Signaling Technology | View profile | 501-1000 | Danvers, Massachusetts, United States, North America | https://www.cellsignal.com |
| Bio SB | View profile | 11-50 | Goleta, California, United States, North America | https://www.biosb.com/ |
| Biogenex | View profile | 51-100 | Fremont, California, United States, North America | https://biogenex.com |
| BD | View profile | 10001+ | Franklin Lakes, New Jersey, United States, North America | https://www.bd.com |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Agilent Technologies Inc | View profile | 17700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | https://www.agilent.com |
| Danaher Corp | View profile | 63000 | 2200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701 | https://www.danaher.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| GE Aerospace | View profile | 125000 | One Financial Center, Suite 3700, Boston, MA, United States, 02111 | https://www.geaerospace.com |
| Siemens AG | View profile | 321000 | Werner-von-Siemens-Strabe 1, Munich, BY, Germany, 80333 | https://www.siemens.com |
| BioMerieux SA | View profile | 13982 | Marcy l’Etoile, Lyon, France, 69280 | http://www.biomerieux.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
Europe tissue diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to tissue diagnostics market will help companies and investors design strategic landscapes.
Immunohistochemistry was the largest segment with a revenue share of 27.89% in 2024. Horizon Databook has segmented the Europe tissue diagnostics market based on immunohistochemistry, in situ hybridization, primary & special staining, digital pathology and workflow, anatomic pathology, molecular pathology covering the revenue growth of each sub-segment from 2018 to 2030.
European market is the second largest market in terms of revenue and is expected to witness significant growth in the forecast period. Companies in Europe are involved in extensive research on cancer and more specifically in development of advanced techniques for cancer detection.
Discovery of new cancer-related genes, studying tumor heterogeneity, and identification of alterations that contribute to tumorigenesis. The above factors are expected to increase the revenue generated from this region. Cancer is a public health burden across the European Union.
The European market is expected to grow owing to rise in aging population coupled with increase in access to healthcare. In August 2021, Unilabs, a Swiss company, in collaboration with Ibex Medical Analytics announced the launch of new AIpowered digital pathology platform across 16 European countries.
Reasons to subscribe to Europe tissue diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe tissue diagnostics market databook
-
Our clientele includes a mix of tissue diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe tissue diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Europe tissue diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe tissue diagnostics market size, by country, 2018-2030 (US$M)
Europe Tissue Diagnostics Market Outlook Share, 2024 & 2030 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
